A Study of a Weight Loss Intervention in People With Endometrial Cancer

NCT06751589 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: Tirzepatide

Sponsor

Memorial Sloan Kettering Cancer Center